Skip to main content

and
  1. No Access

    Article

    Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash

    Cetuximab inhibits the epidermal growth factor receptor (EGFR), and papulopustular eruptions is a frequent side effect. Vitamin K3 (menadione) has preclinically shown to be a potential activator of the EGFR by...

    Jesper Grau Eriksen, Inger Kaalund, Ole Clemmensen in Supportive Care in Cancer (2017)

  2. Article

    Open Access

    The first Danish family reported with an AQP5 mutation presenting diffuse non-epidermolytic palmoplantar keratoderma of Bothnian type, hyperhidrosis and frequent Corynebacterium infections: a case report

    An autosomal dominant form of diffuse non-epidermolytic palmoplantar keratoderma, palmoplantar keratoderma of Bothnian type, is caused by mutations in the AQP5 gene encoding the cell-membrane water channel protei...

    Anne Bruun Krøigård, Liv Eline Hetland, Ole Clemmensen, Diana C. Blaydon in BMC Dermatology (2016)

  3. Article

    Open Access

    Odonto-onycho-dermal dysplasia in a patient homozygous for a WNT10A nonsense mutation and mild manifestations of ectodermal dysplasia in carriers of the mutation

    Odonto-onycho-dermal dysplasia (OODD) is a rare form of ectodermal dysplasia characterized by severe oligodontia, onychodysplasia, palmoplantar hyperkeratosis, dry skin, hypotrichosis, and hyperhidrosis of the...

    Anne Bruun Krøigård, Ole Clemmensen, Hans Gjørup, Jens Michael Hertz in BMC Dermatology (2016)